Newsfeeds Archive - Page 6685 of 19074

2 minute read

CrowdStrike Holdings To Rally Over 31%? Here Are 10 Other Analyst Forecasts For Thursday

September 21, 7:48 AM

Needham increased the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $200 to $215. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares fell 1% to close at $163.89 on Wednesday.

ATLX

1 minute read

Google’s Power Move: Broadcom Ditched in Favor of Marvell Amid AI Chip Wars

By Anusuya Lahiri

September 21, 7:42 AM

Broadcom Inc (NASDAQ: AVGO) stock is trading lower Thursday amid reports of Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL)

AVGO

1 minute read

Why Tesla Shares Are In Reverse Gear Today

By Shanthi Rexaline

September 21, 7:35 AM

In premarket trading, Tesla fell 1.22% to $259.39, according to Benzinga Pro data.

TSLA

2 minute read

Amazon’s Power Play Backfires: Merchants and Regulators Push Back on New Fees

By Anusuya Lahiri

September 21, 7:35 AM

Amazon.com Inc (NASDAQ: AMZN) looks to cancel its planned 2% fee on

AMZN

1 minute read

Travere Therapeutics Announces Confirmatory Data From The Phase 3 PROTECT Study Of FILSPARI Demonstrating Long-Term Kidney Function Preservation In IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint Versus Active Control, Irbesartan

By Benzinga Newsdesk

September 21, 7:34 AM

FILSPARI® (sparsentan) achieved a clinically meaningful difference vs. irbesartan in eGFR total slope (1.0 mL/min/1.73m2 per year) [p= 0.058] and eGFR chronic slope (1.1 mL/min/1.73m2 per year) [p=0.037]. Patients

TVTX

1 minute read

News

Filament Health and Jaguar Health’s Joint Venture Completes Successful Import of Coca Leaf for Psychedelic Research

By Benzinga Newsdesk

September 21, 7:33 AM

Filament Health Corp. (OTCQB:FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or "Filament Health"), a clinical-stage natural psychedelic drug development company, today announced

FLHLF

1 minute read

News

Cybin Advances to Phase 3 Potential: Successful Enrollment Completion in CYB003 Phase 2 Study for Major Depressive Disorder Treatment

By Benzinga Newsdesk

September 21, 7:32 AM

Cybin Inc. (NYSE:CYBN) (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative

CYBN

1 minute read

Toshiba Confirms $14B JIP Takeover Success, Set To Go Private

By Akanksha Bakshi

September 21, 7:30 AM

Toshiba Corp (OTC: TOSBF) (OTC: TOSYY) announces that the $14 billion tender offer from Japan Industrial Partners (JIP)

TOSBF

2 minute read

Watch: Rare Video Of Bitcoin Pioneer Hal Finney’s 1998 Talk On Zero-Knowledge Proofs Resurfaces

By Benzinga Neuro

September 21, 7:29 AM

The crypto community’s latest discovery is a video from a quarter-century ago. In this footage, early Bitcoin (CRYPTO: BTC) pioneer Hal Finney is seen discussing the potential of zero-knowledge proofs, a cornerstone of cryptographic technology.

BTC

2 minute read

McDonald’s, Halliburton And 2 Other Stocks Insiders Are Selling

By Lisa Levin

September 21, 7:24 AM

The Nasdaq 100 closed lower by more than 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

HAL